A clinical trial at Memorial Sloan Kettering Cancer Center has achieved groundbreaking results in treating rectal cancer ...

All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

A Nigerian scientist, Prosper Chukwuemeka is combining data-driven insights with biological research to evolve a smarter and effective cancer treatment.Chukwuemeka’s research targets uncovering the ...

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...